Muscle atrophy in cancer: A role for nutrition and exercise

Applied Physiology, Nutrition and Metabolism

Volumn 34, Issue 5, 2009, Pages 950-956

  Mourtzakis, Marina ^a   Bedbrook, Megan ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Adipose tissue; Body composition; Lean tissue

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; DIET; EATING; ENERGY METABOLISM; EXERCISE; HUMAN; INFLAMMATION; METABOLISM; MUSCLE ATROPHY; NEOPLASM; PHYSIOLOGY; SKELETAL MUSCLE;

ANTINEOPLASTIC AGENTS; DIET; EATING; ENERGY METABOLISM; EXERCISE; HUMANS; INFLAMMATION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASMS;

EID: 73649129899     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H09-075     Document Type: Article

References (92)

1. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. 1999. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257(1): 79-83. doi:10.1006/bbrc.1999.0255. PMID:10092513.
2. Aslani, A., Smith, R.C., Allen, B.J., Pavlakis, N., and Levi, J.A. 2000. The predictive value of body protein for chemotherapy-induced toxicity. Cancer, 88(4): 796-803. doi:10.1002/(SICI)10970142(20000215)88:4<796::AID-CNCR10>3.0.CO;2- P. PMID: 10679649.
3. Bairati, I., Meyer, F., Fradet, Y., and Moore, L. 1998. Dietary fat and advanced prostate cancer. J. Urol. 159(4): 1271-1275. doi:10.1016/S0022-5347(01)63579-1. PMID:9507851.
4. Barnard, R.J., Kobayashi, N., and Aronson, W.J. 2008. Effect of diet and exercise intervention on the growth of prostate epithelial cells. Prostate Cancer Prostatic Dis. 11(4): 362-366. doi:10. 1038/pcan.2008.6. PMID:18283296.
5. Basaria, S., Muller, D.C., Carducci, M.A., Egan, J., and Dobs, A.S. 2006. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer, 106(3): 581-588. doi:10.1002/cncr.21642. PMID:16388523.
6. Baumgartner, R.N., Koehler, K.M., Gallagher, D., Romero, L., Heymsfield, S.B., Ross, R.R., et al. 1998. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147(8): 755-763. PMID:9554417.
7. Biolo, G., Ciocchi, B., Stulle, M., Piccoli, A., Lorenzon, S., Dal Mas, V., et al. 2005. Metabolic consequences of physical inactivity. J. Ren. Nutr. 15(1): 49-53. doi:10.1053/j.jrn.2004.09.009. PMID:15648007.
8. Blüher, M., Bullen, J.W., Jr., Lee, J.H., Kralisch, S., Fasshauer, M., Klöting, N., et al. 2006. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J. Clin. Endocrinol. Metab. 91(6): 2310-2316. doi:10.1210/jc.2005-2556. PMID:16551730.
9. Borugian, M.J., Sheps, S.B., Kim-Sing, C., Van Patten, C., Potter, J.D., Dunn, B., et al. 2004. Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol. Biomarkers Prev. 13(7): 1163-1172. PMID:15247127.
10. Braga-Basaria, M., Dobs, A.S., Muller, D.C., Carducci, M.A., John, M., Egan, J., and Basaria, S. 2006. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J. Clin. Oncol. 24(24): 3979-3983. doi:10.1200/JCO.2006.05.9741. PMID:16921050.
11. Bureyko, T., Hurdle, H., Metcalfe, J.B., Clandinin, M.T., and Mazurak, V.C. 2009. Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro. Br. J. Nutr. 101(7): 990-997. doi:10.1017/S0007114508051684. PMID:18718045.
12. Bylow, K., Mohile, S.G., Stadler, W.M., and Dale, W. 2007. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer? Cancer, 110(12): 2604-2613. doi:10.1002/cncr.23084. PMID:17960609.
13. Canadian Cancer Society and National Cancer Institute of Canada. 008. Canadian cancer statistics 2008. Canadian Cancer Society and National Cancer Institute of Canada, Toronto, Ont.
14. Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., Atkinson, H.H., Penninx, B.W., Lenchik, L., et al. 2005. Sarcopenia, obesity, and inflammation: results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am. J. Clin. Nutr. 82(2): 428-434. PMID:16087989.
15. Chappell, J., Leitner, J.W., Solomon, S., Golovchenko, I., Goalstone, M.L., and Draznin, B. 2001. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J. Biol. Chem. 276(41): 38023-38028. PMID:11500498.
16. Chen, Z., Maricic, M., Nguyen, P., Ahmann, F.R., Bruhn, R., and Dalkin, B.L. 2002. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma. Cancer, 95(10): 2136-2144. doi:10.1002/cncr.10967. PMID:12412167.
17. Corcoran, M.P., Lamon-Fava, S., and Fielding, R.A. 2007. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am. J. Clin. Nutr. 85(3): 662-677. PMID:17344486.
18. Cosquéric, G., Sebag, A., Ducolombier, C., Thomas, C., Piette, F., and Weill-Engerer, S. 2006. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br. J. Nutr. 96(5): 895-901. doi:10.1017/BJN20061943. PMID:17092379.
19. Courneya, K.S., Segal, R.J., Mackey, J.R., Gelmon, K., Reid, R.D., Friedenreich, C.M., et al. 2007. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J. Clin. Oncol. 25(28): 4396-4404. doi:10.1200/JCO.2006.08.2024. PMID: 17785708.
20. Courneya, K.S., Katzmarzyk, P.T., and Bacon, E. 2008. Physical activity and obesity in Canadian cancer survivors: populationbased estimates from the 2005 Canadian Community Health Survey. Cancer, 112(11): 2475-2482. doi:10.1002/cncr.23455. PMID:18428195.
21. Cruz, M.R., Prestes, J.C., Gimenes, D.L., and Fanelli, M.F. 2009. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil. Steril. In press. doi:10.1016/j.fertnstert.2009.02.055. PMID:19339000.
22. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., and Felber, J.P. 981. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes, 30(12): 1000-1007. PMID:7030826.
23. Demark-Wahnefried, W., Hars, V., Conaway, M.R., Havlin, K., Rimer, B.K., McElveen, G., and Winer, E.P. 1997. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am. J. Clin. Nutr. 65(5): 1495-1501. PMID:9129482.
24. Demark-Wahnefried, W., Peterson, B.L., Winer, E.P., Marks, L., Aziz, N., Marcom, P.K., et al. 2001. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 19(9): 2381-2389. PMID:11331316.
25. Demark-Wahnefried, W., Kenyon, A.J., Eberle, P., Skye, A., and Kraus, W.E. 2002. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin. Exerc. Physiol. 4(1): 44-49. PMID: 16946801.
26. Demark-Wahnefried, W., Case, L.D., Blackwell, K., Marcom, P.K., Kraus, W., Aziz, N., et al. 2008. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin. Breast Cancer, 8(1): 70-79. doi:10.3816/CBC.2008.n.005. PMID:18501061.
27. Després, J.P., Cartier, A., Côté, M., and Arsenault, B.J. 2008. The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology. Ann. Med. 40(7): 514-523. doi:10.1080/07853890802004959. PMID:18608131.
28. Dyck, D.J., Heigenhauser, G.J.F., and Bruce, C.R. 2006. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol. (Oxf.) 186(1): 5-16. PMID:16497175.
29. Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., and Giugliano, D. 2003. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA, 289(14): 1799-1804. doi:10.1001/jama.289.14.1799. PMID:12684358.
30. Festa, A., D'Agostino, R., Jr., Tracy, R.P., and Haffner, S.M.; Insulin Resistance Atherosclerosis Study. 2002. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes, 51(4): 1131-1137. doi:10.2337/diabetes.51.4.1131. PMID:11916936.
31. Freedman, R.J., Aziz, N., Albanes, D., Hartman, T., Danforth, D., Hill, S., et al. 2004. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J. Clin. Endocrinol. Metab. 89(5): 2248-2253. doi:10.1210/jc.2003-031874. PMID:15126549.
32. Galvão, D.A., Nosaka, K., Taaffe, D.R., Spry, N., Kristjanson, L.J., McGuigan, M.R., et al. 2006. Resistance training and reduction of treatment side effects in prostate cancer patients. Med. Sci. Sports Exerc. 38(12): 2045-2052. doi:10.1249/01.mss.0000233803.48691.8b. PMID:17146309.
33. Galvão, D.A., Spry, N.A., Taaffe, D.R., Newton, R.U., Stanley, J., Shannon, T., et al. 2008. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 102(1): 44-47. doi:10.1111/j.1464-410X.2008.07539.x. PMID:18336606.
34. Gliozzo, B., Sung, C.K., Scalia, P., Papa, V., Frasca, F., Sciacca, L., et al. 1998. Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway. J. Cell. Biochem. 70(2): 268-280. doi:10.1002/(SICI)1097-4644(19980801) 70:2<268::AID-JCB12>3.0.CO;2-J. PMID:9671232.
35. Goktas, S., Yilmaz, M.I., Caglar, K., Sonmez, A., Kilic, S., and Bedir, S. 2005. Prostate cancer and adiponectin. Urology, 65(6): 1168-1172. doi:10.1016/j.urology.2004.12.053. PMID:15922427.
36. Gong, Z., Neuhouser, M.L., Goodman, P.J., Albanes, D., Chi, C., Hsing, A.W., et al. 2006. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev. 15(10): 1977-1983. doi:10.1158/1055-9965.EPI-06-0477. PMID:17035408.
37. Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M.E., Koo, J., Madarnas, Y., et al. 2002. Fasting insulin and outcome in earlystage breast cancer: results of a prospective cohort study. J. Clin. Oncol. 20(1): 42-51. doi:10.1200/JCO.20.1.42. PMID:11773152.
38. Goodwin, P.J., Ennis, M., Bahl, M., Fantus, I.G., Pritchard, K.I., Trudeau, M.E., et al. 2009. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistanceand are associated with components of the insulin resistance syndrome. Breast Cancer Res. Treat. 114(3): 517-525. doi:10. 1007/s10549-008-0019-0. PMID:18437560.
39. Grossmann, M.E., Nkhata, K.J., Mizuno, N.K., Ray, A., and Cleary, M.P. 2008. Effects of adiponectin on breast cancer cell growth and signaling. Br. J. Cancer, 98(2): 370-379. doi:10. 1038/sj.bjc.6604166. PMID:18182989.
40. Haffner, S.M., Valdez, R.A., Mykkänen, L., Stern, M.P., and Katz, M.S. 1994. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism, 43(5): 599-603. doi:10.1016/0026-0495(94)90202-X. PMID:8177048.
41. Harvie, M.N., Campbell, I.T., Baildam, A., and Howell, A. 2004. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res. Treat. 83(3): 201-210. doi:10.1023/B:BREA.0000014037.48744.fa. PMID:14758090.
42. Harvie, M.N., Howell, A., Thatcher, N., Baildam, A., and Campbell, I. 2005. Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy - a longitudinal study. Br. J. Cancer, 92(4): 673-680. doi:10.1038/sj.bjc.6602357. PMID:15726121.
43. Horiguchi, A., Ito, K., Sumitomo, M., Kimura, F., Asano, T., and Hayakawa, M. 2008. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn. J. Clin. Oncol. 38(2): 106-111. doi:10.1093/jjco/hym158. PMID:18245516.
44. Huffman, D.M., Johnson, M.S., Watts, A., Elgavish, A., Eltoum, I.A., and Nagy, T.R. 2007. Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake. Cancer Res. 67(1): 417-424. doi:10.1158/0008-5472.CAN-061244. PMID:17185379.
45. Ishikawa, M., Kitayama, J., Yamauchi, T., Kadowaki, T., Maki, T., Miyato, H., et al. 2007. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 98(7): 1120-1127. doi:10.1111/j.1349-7006.2007.00486.x. PMID:17459059.
46. Jiang, W., Zhu, Z., and Thompson, H.J. 2009. Effects of physical activity and restricted energy intake on chemically induced mammary carcinogenesis. Cancer Prev. Res. (Phila. Pa.) 2(4): 338-344. doi:10.1158/1940-6207.CAPR-08-0169. PMID:19336733.
47. Kang, J.H., Lee, Y.Y., Yu, B.Y., Yang, B.S., Cho, K.H., Yoon, D.K., and Roh, Y.K. 2005. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res. 28(11): 1263-1269. doi:10.1007/BF02978210. PMID:16350853.
48. Kelesidis, I., Kelesidis, T., and Mantzoros, C.S. 2006. Adiponectin and cancer: a systematic review. Br. J. Cancer, 94(9): 1221-1225. doi:10.1038/sj.bjc.6603051. PMID:16570048.
49. Kutynec, C.L., McCargar, L., Barr, S.I., and Hislop, T.G. 1999. Energy balance in women with breast cancer during adjuvant treatment. J. Am. Diet. Assoc. 99(10): 1222-1227. doi:10.1016/S0002-8223(99)00301-6. PMID:10524385.
50. Laaksonen, D.E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.P., Valkonen, V.P., et al. 2004. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27(5): 1036-1041. doi:10.2337/diacare.27.5.1036. PMID:15111517.
51. Lieffers, J.R., Mourtzakis, M., Hall, K.D., McCargar, L.J., Prado, C.M.M., and Baracos, V.E. 2009. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am. J. Clin. Nutr. 89(4): 1173-1179. doi:10.3945/ajcn.2008. 27273. PMID:19244378.
52. Ligibel, J.A., Campbell, N., Partridge, A., Chen, W.Y., Salinardi, T., Chen, H., et al. 2008. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J. Clin. Oncol. 26(6): 907-912. doi:10.1200/JCO.2007. 12.7357. PMID:18281663.
53. Lorincz, A.M., and Sukumar, S. 2006. Molecular links between obesity and breast cancer. Endocr. Relat. Cancer, 13(2): 279-292. doi:10.1677/erc.1.00729. PMID:16728564.
54. MacInnis, R.J., and English, D.R. 2006. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control, 17(8): 989-1003. doi:10.1007/s10552-006-0049-z. PMID:16933050.
55. Meyer, F., Bairati, I., Shadmani, R., Fradet, Y., and Moore, L. 1999. Dietary fat and prostate cancer survival. Cancer Causes Control, 10(4): 245-251. doi:10.1023/A:1008913307947. PMID: 10482482.
56. Michalakis, K., Williams, C.J., Mitsiades, N., Blakeman, J., Balafouta-Tselenis, S., Giannopoulos, A., and Mantzoros, C.S. 2007. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol. Biomarkers Prev. 16(2): 308-313. doi:10.1158/1055-9965.EPI-06-0621. PMID:17301264.
57. Mourtzakis, M., Prado, C.M.M., Lieffers, J.R., Reiman, T., McCargar, L.J., and Baracos, V.E. 2008. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab. 33(5): 997-1006. doi:10. 1139/H08-075. PMID:18923576.
58. Muller, M., Grobbee, D.E., den Tonkelaar, I., Lamberts, S.W., and van der Schouw, Y.T. 2005. Endogenous sex hormones and metabolic syndrome in aging men. J. Clin. Endocrinol. Metab. 90(5): 2618-2623. doi:10.1210/jc.2004-1158. PMID:15687322.
59. O'Leary, V.B., Marchetti, C.M., Krishnan, R.K., Stetzer, B.P., Gonzalez, F., and Kirwan, J.P. 2006. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J. Appl. Physiol. 100(5): 1584-1589. doi:10.1152/japplphysiol.01336.2005. PMID:16373444.
60. Ornish, D., Weidner, G., Fair, W.R., Marlin, R., Pettengill, E.B., Raisin, C.J., et al. 2005. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 174(3): 1065-1069, discussion 1069-1070. doi:10.1097/01.ju.0000169487.49018.73. PMID:16094059.
61. Payette, H., Roubenoff, R., Jacques, P.F., Dinarello, C.A., Wilson, P.W., Abad, L.W., and Harris, T. 2003. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J. Am. Geriatr. Soc. 51(9): 1237-1243. doi:10.1046/j.1532-5415. 2003.51407.x. PMID:12919235.
62. Pinthus, J.H., Kleinmann, N., Tisdale, B., Chatterjee, S., Lu, J.P., Gillis, A., et al. 2008. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur. Urol. 54(4): 866-873. doi:10.1016/j. eururo.2008.02.044. PMID:18343565.
63. Pottratz, S.T., Bellido, T., Mocharla, H., Crabb, D., and Manolagas, S.C. 1994. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93(3): 944-950. doi:10.1172/JCI117100. PMID:8132780.
64. Prado, C.M.M., Baracos, V.E., McCargar, L.J., Mourtzakis, M., Mulder, K.E., Reiman, T., et al. 2007. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin. Cancer Res. 13(11): 3264-3268. doi:10.1158/1078-0432.CCR-06-3067. PMID:17545532.
65. Prado, C.M.M., Lieffers, J.R., McCargar, L.J., Reiman, T., Sawyer, M.B., Martin, L., and Baracos, V.E. 2008. Prevalence and clinical implications of sarcopenic obesity in patients with solid tu-mours of the respiratory and gastrointestinal tracts: a populationbased study. Lancet Oncol. 9(7): 629-635. doi:10.1016/S14702045(08)70153-0. PMID:18539529.
66. Prado, C.M.M., Baracos, V.E., McCargar, L.J., Reiman, T., Mourtzakis, M., Tonkin, K., et al. 2009. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin. Cancer Res. 15(8): 2920-2926. doi:10.1158/10780432.CCR-08-2242. PMID:19351764.
67. Puglisi, M.J., and Fernandez, M.L. 2008. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J. Nutr. 138(12): 2293-2296. doi:10. 3945/jn.108.097188. PMID:19022947.
68. Purohit, A., and Reed, M.J. 2002. Regulation of estrogen synthesis in postmenopausal women. Steroids, 67(12): 979-983. doi:10. 1016/S0039-128X(02)00046-6. PMID:12398994.
69. Reagan-Shaw, S., Nihal, M., Ahsan, H., Mukhtar, H., and Ahmad, N. 2008. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate, 68(15): 1624-1634. doi:10.1002/pros.20824. PMID:18668529.
70. Robinson, L.E., and Graham, T.E. 2004. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can. J. Appl. Physiol. 29(6): 808-829. PMID:15630152.
71. Schrager, M.A., Metter, E.J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., and Ferrucci, L. 2007. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. 102(3): 919-925. doi:10.1152/japplphysiol.00627.2006. PMID:17095641.
72. Segal, R.J., Reid, R.D., Courneya, K.S., Malone, S.C., Parliament, M.B., Scott, C.G., et al. 2003. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J. Clin. Oncol. 21(9): 1653-1659. doi:10.1200/JCO.2003.09.534. PMID:12721238.
73. Segal, R.J., Reid, R.D., Courneya, K.S., Sigal, R.J., Kenny, G.P., Prud'Homme, D.G., et al. 2009. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J. Clin. Oncol. 27(3): 344-351. doi:10.1200/JCO.2007.15.4963. PMID:19064985.
74. Shaikh, I.A., Brown, I., Schofield, A.C., Wahle, K.W., and Heys, S.D. 2008. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate, 68(15): 1635-1646. doi:10.1002/pros.20830. PMID:18668525.
75. Smith, J.C., Bennett, S., Evans, L.M., Kynaston, H.G., Parmar, M., Mason, M.D., et al. 2001. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J. Clin. Endocrinol. Metab. 86(9): 4261-4267. doi:10.1210/jc.86.9.4261. PMID:11549659.
76. Solerte, S.B., Gazzaruso, C., Bonacasa, R., Rondanelli, M., Zamboni, M., Basso, C., et al. 2008. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am. J. Cardiol. 101(11A): 69E-77E. doi:10.1016/j.amjcard.2008.03. 004. PMID:18514630.
77. Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., Dessypris, N., Chrousos, G.P., and Mantzoros, C.S.; Obesity and Cancer Oncology Group. 2007. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int. J. Cancer, 120(7): 1573-1578. doi:10.1002/ijc.22526. PMID:17205522.
78. Strom, S.S., Wang, X., Pettaway, C.A., Logothetis, C.J., Yamamura, Y., Do, K.-A., et al. 2005. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin. Cancer Res. 11(19 Pt 1): 6889-6894. doi:10.1158/1078-0432.CCR-04-1977. PMID:16203779.
79. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell, 83(7): 1263-1271. doi:10.1016/0092-8674(95)90151-5. PMID:8548812.
80. Tayek, J.A., Heber, D., Byerley, L.O., Steiner, B., Rajfer, J., and Swerdloff, R.S. 1990. Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism, 39(12): 1314-1319. doi:10.1016/00260495(90)90190-N. PMID:2123281.
81. Tokmakidis, S.P., and Volaklis, K.A. 2003. Training and detraining effects of a combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease. J. Cardiopulm. Rehabil. 23(3): 193-200. doi:10.1097/00008483200305000-00006. PMID:12782903.
82. Tymchuk, C.N., Barnard, R.J., Heber, D., and Aronson, W.J. 2001. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J. Urol. 166(3): 1185-1189. doi:10.1016/S0022-5347(05)65943-5. PMID:11490320.
83. van Londen, G.J., Levy, M.E., Perera, S., Nelson, J.B., and Greenspan, S.L. 2008. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit. Rev. Oncol. Hematol. 68(2): 172-177. doi:10.1016/j. critrevonc.2008.06.006. PMID:18706829.
84. Vogiatzis, I., Stratakos, G., Simoes, D.C., Terzis, G., Georgiadou, O., Roussos, C., and Zakynthinos, S. 2007. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax, 62(11): 950-956. doi:10.1136/thx.2006.069310. PMID:17573449.
85. von Hafe, P., Pina, F., Pérez, A., Tavares, M., and Barros, H. 2004. Visceral fat accumulation as a risk factor for prostate cancer. Obes. Res. 12(12): 1930-1935. doi:10.1038/oby.2004.242. PMID:15687393.
86. Vona-Davis, L., and Rose, D.P. 2007. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr. Relat. Cancer, 14(2): 189-206. doi:10.1677/ERC-06-0068. PMID:17639037.
87. Windsor, P.M., Nicol, K.F., and Potter, J. 2004. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer, 101(3): 550-557. doi:10.1002/cncr.20378. PMID:15274068.
88. Xue, F., and Michels, K.B. 2007. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am. J. Clin. Nutr. 86(3): s823-s835. PMID:18265476.
89. Yassine, H.N., Marchetti, C.M., Krishnan, R.K., Vrobel, T.R., Gonzalez, F., and Kirwan, J.P. 2009. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults - a randomized clinical trial. J. Gerontol. A Biol. Sci. Med. Sci. 64(1): 90-95. PMID:19164269.
90. You, T., and Nicklas, B.J. 2008. Effects of exercise on adipokines and the metabolic syndrome. Curr. Diab. Rep. 8(1): 7-11. doi:10.1007/s11892-008-0003-4. PMID:18366992.
91. Zhou, Q., Du, J., Hu, Z., Walsh, K., and Wang, X.H. 2007. Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and fatty acids. Endocrinology, 148(12): 5696-5705. doi:10.1210/en.2007-0183. PMID: 17761767.
92. Zhu, Z., Jiang, W., McGinley, J.N., and Thompson, H.J. 2009. Energetics and mammary carcinogenesis: effects of moderate-intensity running and energy intake on cellular processes and molecular mechanisms in rats. J. Appl. Physiol. 106(3): 911-918. doi:10.1152/japplphysiol.91201.2008. PMID:19095749.